Exor Investments (UK) LLP

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1732768
Institutional-grade research for retail investors

13F Reported Value

$5.1B

incl. option notional

Equity Holdings

$5.0B

Option Notional

$21.1M

$0 puts / $21.1M calls

Holdings

35

Latest Filing

2026-03-31

Filing Quarter

Q1 2026

Portfolio Overview

Exor Investments (UK) LLP disclosed 35 positions worth $5.1B in its Form 13F-HR for Q1 2026$5.0B in common stock plus $21.1M of put/call option positions (reported at underlying notional value, not premium at risk), led by $TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD) at 16.6% of the equity portfolio, followed by $CVNA and $PSKY. During the quarter the fund opened 3 new positions and exited 7 — including a new stake in $NBIS and a full exit from $H. The portfolio is most concentrated in Energy (19.2% of disclosed assets). All figures are sourced directly from Exor Investments (UK) LLP’s Form 13F-HR filing with the SEC under CIK 1732768.

Sector Allocation

EnergyHealthcareConsumer DiscretionaryMaterialsCommunication ServicesTechnology

AUM History

Top Equity Holdings by Value

Option Positions

13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.

$SLBCALL$21M notional

Quarterly Activity — Q1 2026

Click any card to unlock

Top Holdings

AI Quality Scored

Unlock AI quality scores for every holding

32-signal composite ranking on each of Exor Investments (UK) LLP's 35 positions.

Showing top 10 of 35 holdings.

Sector Allocation

Energy

$967.5M

Healthcare

$954.0M

Consumer Discretionary

$851.5M

Materials

$794.7M

Communication Services

$696.9M

Technology

$460.9M

Other

$238.9M

Industrials

$71.5M

Full Holdings — Exor Investments (UK) LLP (Q1 2026)

All 35 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.

#TickerCompanyValueWeightQoQQuality
1TEVA$TEVATEVA PHARMACEUTICAL INDUSTRIES LTD$836.5M16.6%-2%
2CVNA$CVNACARVANA CO.$801.1M15.9%-11%69.2
3PSKY$PSKYParamount Skydance Corp$417.1M8.3%-2%62.5
4VAL$VALValaris Ltd$363.4M7.2%-0%
5NG$NGNOVAGOLD RESOURCES INC$330.8M6.6%+5%
6RRC$RRCRANGE RESOURCES CORP$325.0M6.4%-0%82.8
7VEON$VEONVEON Ltd.$279.7M5.5%-0%
8SLB$SLBSLB LIMITED/NV$279.1M5.5%+30%63.2
9SBSW$SBSWSibanye Stillwater Ltd$246.2M4.9%-31%
10VANECK ETF TRUST$238.9M4.7%-24%
11AG$AGFIRST MAJESTIC SILVER CORP$215.1M4.3%-0%
12NVDA$NVDANVIDIA CORP$107.1M2.1%+19%90.2
13TSM$TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTD$93.7M1.9%+1%
14TEM$TEMTempus AI, Inc.$64.0M1.3%+24%38.2
15NET$NETCloudflare, Inc.$61.9M1.2%+71%52.6
16ISRG$ISRGINTUITIVE SURGICAL INC$60.6M1.2%+22%81.4
17MELI$MELIMERCADOLIBRE INC$41.6M0.8%+19%77.5
18NOW$NOWServiceNow, Inc.$40.8M0.8%+37%76
19AUR$AURAurora Innovation, Inc.$40.1M0.8%+19%9.8
20MRNA$MRNAModerna, Inc.$38.8M0.8%+53%15.9
21PONY$PONYPony AI Inc.$31.4M0.6%-19%
22JOBY$JOBYJoby Aviation, Inc.$30.9M0.6%+19%28.7
23TSLA$TSLATesla, Inc.$26.0M0.5%+19%50.1
24SLB$SLBCALLSLB LIMITED/NV$21.1M-77%63.2
25RXRX$RXRXRECURSION PHARMACEUTICALS, INC.$18.1M0.4%+19%13.6
26NBIS$NBISNebius Group N.V.$13.4M0.3%NEW
27APG$APGAPi Group Corp$12.4M0.3%+0%61.3
28AMZN$AMZNAMAZON COM INC$8.8M0.2%+0%74.6
29MSFT$MSFTMICROSOFT CORP$4.6M0.1%-86%83.7
30DUOL$DUOLDuolingo, Inc.$3.9M0.1%+19%82
31RKT$RKTRocket Companies, Inc.$2.5M0.1%-41%
32HMY$HMYHARMONY GOLD MINING CO LTD$2.5M0.1%-97%
33KKR$KKRKKR & Co. Inc.$2.5M0.1%NEW49.8
34OWL$OWLBLUE OWL CAPITAL INC.$2.2M0.0%NEW59.4
35BABA$BABAAlibaba Group Holding Ltd$2.1M0.0%+0%

New Positions (3)

NBIS$NBIS Nebius Group N.V.$13.4M
KKR$KKR KKR & Co. Inc.$2.5M
OWL$OWL BLUE OWL CAPITAL INC.$2.2M

Exited Positions (7)

H$H Hyatt Hotels Corp
CRH$CRH CRH PUBLIC LTD CO
RUN$RUN Sunrun Inc.
PRMB$PRMB Primo Brands Corp
VRT$VRT Vertiv Holdings Co
DNA$DNA Ginkgo Bioworks Holdings, Inc.
UUUU$UUUU ENERGY FUELS INC

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

to search all 8,700+ institutional filers.

Available Analysis

13F Pro tracks comprehensive institutional data for Exor Investments (UK) LLP including:

Full 13F portfolio with all holdings
Quarter-over-quarter position changes
Accumulation & distribution patterns
Sector allocation breakdown
Historical portfolio evolution
New positions & complete exits
Concentration analysis
Peer comparison with similar funds
AI-powered portfolio insights

Track Exor Investments (UK) LLP's Full Portfolio

See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Exor Investments (UK) LLP and 8,700+ other institutional investors.

View Pricing

Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

AI-Powered Hedge Fund Analysis: Exor Investments (UK) LLP

13F Pro is an AI hedge fund tracker and stock research platform. For Exor Investments (UK) LLP (SEC CIK: 1732768), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Exor Investments (UK) LLP's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.